Mary Jo Laffler
Executive Editor, US Commercial/R&D News
Washington DC, USA
+21 year(s) experience
Scrip, Pink Sheet
The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions.
Scrip
In another year roundly critiqued as being “quiet” on major clinical advances, the American Society of Clinical Oncology annual meeting allowed other areas to shine.
Citeline, Scrip, Biomedtracker, Datamonitor Healthcare
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.
Topic Clinical trials
Scrip
Merck's PD-1 inhibitor holds the first cancer indication based on biomarkers rather than tumor location. The most significant market will be colorectal cancer.
Topic Drug approval
Scrip
Amgen has already reported the positive topline result of its FOURIER cardiovascular outcomes trial for its PCSK9 inhibitor Repatha, but analysts from Datamonitor Healthcare and Biomedtracker lay out the reasons to check out the full results and other highlights at the upcoming American College of Cardiology meeting
Scrip
Using Pharmapremia data, we analyze performance metrics for a select group of leading cancer companies to see where the sticking points are and who is winning at industry’s most important race.
Topic Cancer Strategy Company analysis
Scrip
29 Sep 2020
Scrip
11 Sep 2020
HBW Insight
06 Aug 2020
Scrip
06 Aug 2020
Pink Sheet
31 Jul 2020
Scrip
26 Jul 2020
Scrip
27 Apr 2020
Scrip
22 Oct 2019
Scrip
30 Jul 2019
Pink Sheet
02 Jun 2019
Pink Sheet
16 May 2019
Scrip
25 Apr 2019
Scrip
24 Apr 2019
Pink Sheet
12 Mar 2019
Scrip
14 Jan 2019